Abstract |
The purified fraction 3 of polysaccharides from Fuzhuan brick tea (FBTPS-3) could attenuate the colitis and modulate the gut microbiota. However, the relationship between anti-inflammatory effect of FBTPS-3 and the gut microbiota is still unknown. Thus, the anaerobic fermentation in vitro was used to investigate the potential mechanism. FBTPS-3 could be utilized and degraded by gut microbiota from inflammatory bowel disease (IBD) subjects. Furthermore, FBTPS-3 could modulate the composition and structure of IBD gut microbiota toward to that of healthy group. FBTPS-3 showed a superior modulated effect on IBD gut microbiota by increasing Bacteroides and decreasing Escherichia/Shigella. Furthermore, the fermentation solution rather than FBTPS-3 itself showed anti-inflammatory effects on lipopolysaccharide-treated RAW264.7 macrophages, which might be due to the metabolites such as short-chain fatty acids (SCFAs). Thus, FBTPS-3 can be expected as novel prebiotics for treatment of IBD via modulating gut microbiota, and promoting the production of SCFAs.
|
Authors | Guijie Chen, Mingjia Wang, Ziqi Zeng, Minhao Xie, Weiqi Xu, Yujia Peng, Wangting Zhou, Yi Sun, Xiaoxiong Zeng, Zhonghua Liu |
Journal | Food chemistry
(Food Chem)
Vol. 391
Pg. 133203
(Oct 15 2022)
ISSN: 1873-7072 [Electronic] England |
PMID | 35597036
(Publication Type: Journal Article)
|
Copyright | Copyright © 2022 Elsevier Ltd. All rights reserved. |
Chemical References |
- Anti-Inflammatory Agents
- Fatty Acids, Volatile
- Polysaccharides
- Tea
|
Topics |
- Anti-Inflammatory Agents
(pharmacology)
- Colitis
(chemically induced, drug therapy)
- Fatty Acids, Volatile
(metabolism)
- Fermentation
- Gastrointestinal Microbiome
- Humans
- Inflammatory Bowel Diseases
(drug therapy)
- Polysaccharides
(chemistry, pharmacology)
- Tea
(chemistry)
|